Jennifer Grant
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Epidemiology
- Applied Microbiology and Biotechnology top 5%
- Endocrinology top 10%
- Co-authors
- Diane RoscoeKatherine PlewesDavid A. BoydMichael R. MulveyElizabeth BryceLeslie ForresterAmanda WilmerMelanie C. M. Murray
- Topics
- COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)Infection Control in Healthcare (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEEmerging infectious diseases
- Partner nations
- CanadaUnited StatesCzechia
In The Last Decade
Jennifer Grant
35 papers receiving 451 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 172
- Molecular Medicine 140
- Epidemiology 93
- Applied Microbiology and Biotechnology 64
- Endocrinology 63
Countries citing papers authored by Jennifer Grant
This map shows the geographic impact of Jennifer Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Grant more than expected).
Fields of papers citing papers by Jennifer Grant
This network shows the impact of papers produced by Jennifer Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Grant. The network helps show where Jennifer Grant may publish in the future.
Co-authorship network of co-authors of Jennifer Grant
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Grant. A scholar is included among the top collaborators of Jennifer Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Grant. Jennifer Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 24 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 21 | |
| 10 | 7 | |
| 11 | 16 | |
| 12 | 22 | |
| 13 | 14 | |
| 14 | 15 | |
| 15 | 5 | |
| 16 | 12 | |
| 17 | 140 | |
| 18 | 35 | |
| 19 | 14 | |
| 20 | 5 |
About Jennifer Grant
Jennifer Grant is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 39 papers that have together received 470 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Infection Control in Healthcare (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (64 citations), Molecular Medicine (140 citations) and Endocrinology (63 citations). Jennifer Grant has collaborated with scholars based in Canada, United States and Czechia. Frequent co-authors include Diane Roscoe, Katherine Plewes, David A. Boyd, Michael R. Mulvey, Elizabeth Bryce, Leslie Forrester, Amanda Wilmer, Melanie C. M. Murray, Paul Chilton and Annalee Yassi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.